Market Closed -
OTC Markets
20:59:48 16/07/2024 BST
5-day change
1st Jan Change
0.19
USD
0.00%
+7.04%
+35.71%
Presentation Operator MessageOperator (Operator)Good morning, ladies and gentlemen, and welcom...
Transcript : Elite Pharmaceuticals, Inc., Q4 2024 Earnings Call, Jul 02, 2024
07-02
Elite Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024
07-01
CI
Elite Pharmaceuticals Receives Fda Approval for Generic Methotrexate
05-20
CI
Transcript : Elite Pharmaceuticals, Inc., Q3 2024 Earnings Call, Feb 15, 2024
02-15
Elite Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
02-14
CI
Elite Pharmaceuticals, Inc. Files ANDA with US FDA to Market Central Nervous System Stimulant
12-26
CI
Elite Pharmaceuticals Announces First Product Shipment of Generic Adderall XR to Marketing Partner Prasco, LLC
12-12
CI
Transcript : Elite Pharmaceuticals, Inc., Q2 2024 Earnings Call, Nov 15, 2023
11-15
Elite Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
11-14
CI
Elite Pharmaceuticals Files Anda with US FDA to Market Opiate Analgesic Product
25/09/23
CI
Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer
07/09/23
CI
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
28/08/23
CI
Transcript : Elite Pharmaceuticals, Inc., Q1 2024 Earnings Call, Aug 15, 2023
15/08/23
Elite Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023
14/08/23
CI
Transcript : Elite Pharmaceuticals, Inc., 2023 Earnings Call, Jun 30, 2023
30/06/23
Elite Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
29/06/23
CI
Elite Pharmaceuticals, Inc Appoints Mark Pellegrino as its Chief Financial Officer
03/05/23
CI
Elite Pharmaceuticals Files ANDA with US FDA to Market Antimetabolite Product
20/04/23
CI
Elite Pharmaceuticals, Inc. Announces Resignation of Robert Chen as Treasurer and Secretary
28/02/23
CI
Elite Pharmaceuticals, Inc. Announces Resignation of Robert Chen as Chief Financial Officer
28/02/23
CI
Transcript : Elite Pharmaceuticals, Inc., Q3 2023 Earnings Call, Feb 15, 2023
15/02/23
Elite Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
14/02/23
CI
Elite Pharmaceuticals Reports Positive Results from A Pivotal Bioequivalence Study
07/02/23
CI
Transcript : Elite Pharmaceuticals, Inc., Q2 2023 Earnings Call, Nov 15, 2022
15/11/22
Elite Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
14/11/22
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and distributes niche generic products. The Company specializes in developing and manufacturing oral, controlled-release drug products. It owns multiple generic products which has been licensed to Prasco, LLC and TAGI Pharma. The Companyâs segments include Abbreviated New Drug Applications (ANDA) and New Drug Application (NDA). The Companyâs products include Phentermine HCl 37.5mg tablets, Loxapine Succinate 5mg, 10mg, 25mg and 50gm capsules, Phentermine HCl 15mg and 30mg capsules, Naltrexone HCl 50mg tablets, Dantrolene Sodium Capsules 25mg, 50mg and 100mg, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Immediate Release 5mg, 7.5mg, 10mg, 12.5mg, 15mg, 20mg and 30mg tablets, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended Release 5mg, 10mg, 15mg, 20mg, 25mg, and 30mg capsules and others.
More about the company
1st Jan change
Capi.
+35.71% 203M +25.40% 45.54B +36.83% 24.51B +27.12% 16.48B +21.19% 14.66B +71.91% 14.3B -0.05% 6.79B -11.88% 6.73B +15.08% 5.87B -8.87% 5.73B
Generic Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1